Oryzon Genomics Eulerpool Nyheter

Oryzon Genomics Eulerpool News

Oryzon Genomics Aktiens nyheter

Oryzon Genomics bevakas av många journalister och investerare över hela världen. De senaste Oryzon Genomics nyheterna samlar vi här.

• 3 september ·

  Yahoo
  ORYZON Continues to Strengthen its Patent Portfolio for Vafidemstat with Additional “Decision to Grant” Communications
• 29 augusti ·

  Yahoo
  ORYZON to Provide Corporate Progress Updates at Several Events in September
• 31 juli ·

  Yahoo
  ORYZON reports financial results and corporate update for half-year ending June 30, 2024
• 8 juli ·

  Yahoo
  ORYZON Receives “Decision to grant” for Two Important Patents for Vafidemstat in Japan
• 28 juni ·

  Yahoo
  ORYZON Announces Voting Results from its 2024 Annual General Meeting of Shareholders
• 26 juni ·

  Yahoo
  ORYZON Announces Presentation of Final Data From PORTICO, Vafidemstat’s Global Phase IIb Trial in Borderline Personality Disorder, at the 37th ECNP Annual Conference
• 14 juni ·

  Yahoo
  ORYZON Presents Preliminary Data From Ongoing Phase Ib FRIDA Trial with Iadademstat Plus Gilteritinib in Relapsed/Refractory FLT3-mut AML Patients at EHA-2024
• 3 juni ·

  Yahoo
  ORYZON Announces Journal Publication of Final Phase IIa ALICE Results with Iadademstat in The Lancet Hematology
• 30 maj ·

  Yahoo
  ORYZON to Provide Corporate Progress Updates at Several Events in June
• 29 maj ·

  Yahoo
  ORYZON Selected as Associated Partner in the First Important Project of Common European Interest (IPCEI) in the Health Sector (Med4Cure Project)